XEN1101

Phase 3

41%

Phase 3

Development Phase

Upcoming Catalysts

Historical Events

Regulatory Approvals

Upcoming Catalysts

Oct 2026~

XENE⭐Phase 3Phase 3

XEN1101 Phase 3 Results Expected

XEN1101 • Primary Generalized Tonic-Clonic Seizures

Dec 2025~

XENE⭐Phase 3Phase 3

XEN1101 Phase 3 Results Expected

XEN1101 • Primary Generalized Tonic-Clonic Seizures

Drug Information

Target Indication

Primary Generalized Tonic-Clonic Seizures

Clinical Trial